Stay updated on Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    New entries for Contacts/Locations and Study Status were added on 2025-11-14 and 2025-12-02, and an entry was removed on 2025-11-10.
    Difference
    0.1%
    Check dated 2025-12-02T17:44:19.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.2 on the page header. This reflects a backend/version update with no visible changes to the study record content or user experience.
    Difference
    0.0%
    Check dated 2025-11-25T14:44:12.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site-wide government funding status notice banner has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-18T07:25:58.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    On 2025-11-10, the history adds Contacts/Locations and Study Status (entry 437). A deletion was recorded on 2025-09-22.
    Difference
    0.1%
    Check dated 2025-11-11T03:23:33.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    New entries appear in the Record History, reflecting updated version dates and status changes for the study (including status and contacts/locations updates). These are administrative changes and do not alter the study data.
    Difference
    0.0%
    Check dated 2025-10-27T20:54:46.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.
    Difference
    3%
    Check dated 2025-10-06T08:12:15.000Z thumbnail image

Stay in the know with updates to Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Docetaxel for KRAS+ NSCLC Clinical Trial page.